Printing the pill also means the company can package drugs more compactly, with the ability to have up to 1000 milligrams in one easily dissolvable pill, according to the BBC.

Don Wetherhold, Chief Executive of Aprecia, said in a statement: “By combining 3D printing technology with a highly-prescribed epilepsy treatment, Spritam is designed to fill a need for patients who struggle with their current medication experience.”

“This is the first in a line of central nervous system products Aprecia plans to introduce as part of our commitment to transform the way patients experience taking medication,” he said.